Preparation and evaluation of a new nano pharmaceutical excipients and drug delivery system based in polyvinylpyrrolidone and silicate

Journal of Pharmacy and Pharmaceutical Sciences

Volumn 14, Issue 1, 2011, Pages 17-35

  Dornelas, Camila Braga ^a   da Silva, Alex Moura ^a   Dantas, Cide Brizio ^a   Rodrigues, Carlos Rangel ^a   Coutinho, Sandra Solange ^a   Sathler, Plínio Cunha ^b   Castro, Helena Carla ^b   Dias, Luiza Rosaria Sousa ^b   de Sousa, Valéria Pereira ^a   Cabral, Lúcio Mendes ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLAMMONIUM MONTMORILLONITE; EXCIPIENT; GLYCEROL STEARATE; METHYLDOPA; NANOCOMPOSITE; NANOMATERIAL; POVIDONE; SILICATE; THEOPHYLLINE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG SCREENING; DRUG SOLUBILITY; DRUG SYNTHESIS; INTERCALATION COMPLEX; STOMACH JUICE; SUSTAINED DRUG RELEASE; TABLET; TABLET COMPRESSION; THERMOGRAVIMETRY; X RAY DIFFRACTION;

EID: 79951804317     PISSN: None     EISSN: 14821826     Source Type: Journal    
DOI: 10.18433/j3hc72     Document Type: Article

References (35)

1. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release, 2001;70:1-20.
2. Lee SC, Ruegsegger M, Barnes PD, Smith BR, Ferrari M. Therapeutic nanodevices. In: Bhushan, B., The Nanotechnology Handbook, 2nd Ed, Springer-Verlag Heidelberg, German, pp 279-322, 2004.
3. Nijhara R, Balakrishnan K. Bringing nanomedicines to market: regulatory challenges, opportunities, and uncertainties. Nanomedicine 2006;2:127-36.
4. Bala P, Samantaray BK, Srivastava SK. Synthesis and characterization of Na-montmorillonitealkylammonium intercalation compounds. Mater Res Bull. 2000;35:1717-24.
5. Shah SS, Kulkarni MG, Mashelkar RA. pH dependent zero order released from glassy hydrogels: penetration vs. diffusion control. J Control Rel, 1991;15;121-32.
6. Chiou WL, Riegelman S. Pharmaceutical applications of Solid Dispersions. J Pharm Sci. 1971;60:1281-302.
7. Ebube NK, Hikal AH, Wyandt CM, Beer DC, Miller LG, Jones AB. Sustained release of acetaminophen from heterogeneous matrix tablets: influence of polymer ratio, polymer loading and coactive on drug release. Pharm Dev Technol. 1997;2:161-70.
8. Chien YW. Fundamentals of controlled-release drug administration. In: Novel Drug Delivery Systems: Fundamentals, Development Concepts, Biomedical Assessments, Marcel-Dekker, New York. pp. 43- 138, 1982.
9. Chambin O, Champion D, Debray C,; Rochat- Gonthier MH, Le Meste M, Pourcelot Y. Effects of different cellulose derivatives on drug release mechanism studied at a preformulation stage. J Control Release 2004;95:101-8.
10. Amidon GL, Merfeld AE, Dressman JB. Concentration and pH dependency of a-methyldopa absorption in rat intestine. J Pharm Pharmacol. 1996;38:363-8.
11. Siepmann J, Peppas NA. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC) Adv Drug Deliver Rev. 2001;48:139-57.
12. Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm. 2000;50:47-60.
13. Schiermeier S, Schmidt PC. Fast dispersible ibuprofen tablets. Eur J Pharm Sci. 2002;15:295-305.
14. United States Pharmacopoeia 31 and National Formulary 26. Rockville, MD: United States Pharmacopoeia Convention, 2008.
15. Rembischevski P, Gemal AL. Determination of the Influence of Borate Ion on the degradation of L-a- methyldopa using RP-HPLC with photodiode array detection. J Liq Chromatogr Relat Technol. 2001; 24:2661-2671.
16. Talukdar MM, Kinget R. Swelling and drug release behavior of xanthan gum matrix tablets. Int J Pharm. 1995;120:63-72.
17. United States Pharmacopoeia 31 and National Formulary 26. Rockville, MD: United States Pharmacopoeia Convention, pp. 3374-3375, 2008.
18. United States Pharmacopoeia 31 and National Formulary 26. Rockville, MD: United States Pharmacopoeia Convention, pp. 2675, 2008.
19. Lee PI. Kinetics of drug release from hydrogel matrices. J Controlled Release1985;2:277-280
20. Sun CQ, Zhou DL, Grant DJW, Young VG. Characterization of Crystalline Phase- Transformations in Theophylline by Time-Domain Terahertz Spectroscopy. Acta Crystallogr., Sect. E: Struct. Rep. Online 2002, 58, O368.
21. Gurina GI, Savchenko KV. Montmorillonite intercalation complexes and their interaction with epoxy compounds. Theor Exp Chem. 1994;29:63-65.
22. NHI. The Up-and-Down Procedure: Peer panel Report. In: The Revised Up-and-Down Procedure: A Test Method for Determining the Acute Oral Toxicity of Chemicals. NICEATM-ICCVAM, pp. I- 4,2001.
23. Simon S, Cerf DL, Picton L, Muller G. Adsorption of cellulose derivatives onto montmorillonite: a SEC-MALLS study of molar masses influence. Colloids Surf A Physicochem Eng Asp. 2002;203:77-86.
24. Takeuchi H, Nagira S, Yamamoto H, Kawashima Y. Die wall pressure measurement for evaluation of compaction property of pharmaceutical materials. Int J Pharm. 2004;274:131-8.
25. Velasco MV, Muñoz A, Jiménez-Castellanos MR, Castellano I, Goñi I, Gurruchaga M. In vitro evaluation of sustained-release matrix tablets prepared with new modified polymeric carbohydrates. Int J Pharm. 1996;136:107-15.
26. Rowe RC, Sheskey PJ, Owen SC. Handbook of Pharmaceutical Excipients. 5 ed. Pharmaceutical Press, Great Britain, 2006.
27. Xie W, Gao Z, Pan WP, Hunter D, Singh A, Vaia R. Thermal Degradation Chemistry of Alkyl Quaternary Ammonium Montmorillonite. Chem. Mater. 2001;13: 2979-90.
28. Katikaneni PR, Upadrashta SM, Neau SH, Mitra AK. Ethylcellulose matrix controlled release tablets of a water-soluble drug. Int J Pharm. 1995;123:119-15.
29. Siepmann J, Peppas NA. Modelling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev. 2001;48:139-157.
30. Abdou, HM. The Science and Practice of Pharmacy. 20 ed. Lippincott Williams & Wilkins, Philadelphia, USA, 2000.
31. Khan MZI. Dissolution testing for sustained or controlled release oral dosage forms and correlation with in vivo data: challenges and opportunities. Int J Pharm. 1996;140:131-43.
32. Craig, DQM. The mechanisms of drug release from solid dispersions in water-soluble polymers. Int J Pharm. 2002;231:131-44.
33. Paradkar A, Ambike AA, Jadhav BK, Mahadik KR. Characterization of curcumin-PVP solid dispersion obtained by spray drying. Int J Pharm. 2004;271:281-6.
34. Porubcan LS. Mechanism of adsorption of Clindamycin and Tetracycline by Montmorillonite. J Pharm Sci. 1978;67:1081-7.
35. McGinity JW, Harris MR. Influence of a Montmorillonite Clay on the Properties of Griseofulvin Tablets. Drug Dev Ind Pharm. 1980;6:49-59.